Lupus Nephritis (LN) is one of the most common and serious manifestations in SLE patients that causes significant morbidity and mortality. Current conventional biomarkers for lupus nephritis like urine sediments, proteinuria, anti-dsDNA antibodies and C3 or C4 are sometimes mislead for prediction of treatment response. Recently IL-2 R alpha has shown to be a good marker to predict treatment response of lupus nephritis.
This is an entrancing case report of extremely severe metabolic acidosis occurred to a 46-year-old female who was admitted to intensive care medicine, Ninewells hospital. She presented with vomiting and collapsed with significant deranged metabolic acidosis. Despite carrying very guarded prognosis on admission, fortunately she survived following effective management from multidisciplinary team in the hospital. This case describes the metabolic acidosis in association with the mortality including the clinical presentation, management and the outcome.
The Department of Nephrology publishes peer-reviewed Open Access papers submitted by medical professionals, research experts, and highly qualified experts in this domain.
The papers published in Department of Nephrology can be accessed by anyone at any time. We make the paper searchable and index it in leading medical journal repositories all over the world. We make sure that the published papers find an attentive and global audience that appreciates the authors’ work.
The Editors actively encourages submissions of papers related to clinical aspects of basic research and trials that will have an impact on the understanding of health and disease. Case reports, focused research on a broad range of disciplines as well as experimental papers may be submitted. Besides, authors may contribute short reviews (by invitation from the Editor) and letters to the editor. This journal adheres to the policies recommended by The Committee on Publication Ethics (COPE).
The following subject areas are covered by The Department of Nephrology for papers submission however the accepted papers are not constrained only to the listed areas.
Please direct any enquiry or submit papers to: email@example.com